Simon Senanu: A Stepwise Laboratory Approach for aPTT Prolongation
Simon Senanu, Medical Laboratory Scientist at Perkins Medical Centre, shared a post on LinkedIn:
“aPTT Prolongation – A Stepwise Laboratory Approach
A prolonged activated partial thromboplastin time (aPTT) is a common laboratory finding.
But not all prolongations indicate a bleeding disorder.
The key lies in a structured interpretation.
What Does aPTT Assess?
aPTT evaluates the intrinsic and common pathways:
- Factor XII, XI, IX, VIII
- Factor X, V, II (prothrombin), fibrinogen
Any defect, inhibitor, or interference in these pathways can prolong aPTT.
Step 1: Confirm the Result
Before interpretation, rule out pre-analytical errors:
- Underfilled citrate tube (incorrect blood-to-anticoagulant ratio)
- Clotted sample
- Heparin contamination (e.g., line draws)
Always repeat if the result is unexpected.
Step 2: Perform a Mixing Study
Mix patient plasma with normal plasma (1:1):
- Correction of aPTT – Suggests factor deficiency
- No correction – Suggests circulating inhibitor
This is the most critical step in narrowing the cause.
If It Corrects – Think Factor Deficiency
Common etiologies:
- Hemophilia A (Factor VIII deficiency)
- Hemophilia B (Factor IX deficiency)
- Factor XI deficiency
- Severe von Willebrand disease (via reduced Factor VIII)
Factor XII deficiency can prolong aPTT but does not cause bleeding – a key diagnostic trap.
If It Does Not Correct – Think Inhibitor or Anticoagulant
Key causes:
- Lupus anticoagulant (LA)
- Specific factor inhibitors (e.g., acquired Factor VIII inhibitor)
- Heparin or direct anticoagulants
Lupus anticoagulant prolongs phospholipid – dependent assays but is associated with thrombosis.
Pattern Recognition in Practice
- Isolated prolonged aPTT plus bleeding – Hemophilia or severe vWD
- Isolated prolonged aPTT plus thrombosis – Lupus anticoagulant
- Prolonged aPTT plus normal PT plus no symptoms – Likely benign cause or artifact
- Prolonged aPTT plus clinical deterioration – Consider acquired inhibitor
Laboratory Pitfalls
- Heparin contamination mimicking inhibitor patterns
- Acute phase reactions altering factor levels
- Delayed testing affecting labile factors (especially Factor VIII)
Always integrate clinical plus laboratory data.
Clinical Significance
A prolonged aPTT can indicate:
- Inherited bleeding disorders
- Acquired inhibitors
- Antiphospholipid syndrome
- Anticoagulant therapy effects
Misinterpretation can lead to inappropriate management.
Laboratory Takeaway
aPTT prolongation is not a diagnosis – it is a starting point.
Think systematically:
Error – Mixing study – Deficiency vs inhibitor – Clinical correlation
When you see a prolonged aPTT, what’s your immediate instinct – repeat the test or proceed directly to a mixing study?”

Other posts featuring Simon Senanu on Hemostasis Today.
-
Apr 1, 2026, 15:30Liza Bulsara: Early Clinical Warning Signs of Pediatric Hematologic Disorders
-
Apr 1, 2026, 15:18Gregory Piazza: Proud Moment for Thrombosis Research Group at ACC.26
-
Apr 1, 2026, 15:10Nathan Connel: How Policy Changes Redefine Medical Care
-
Apr 1, 2026, 14:58Steve Cleveland: Tumor-Educated Platelets as a Platform for Early Cancer Detection
-
Apr 1, 2026, 14:53Hayley Emma Arron: Supporting Future Strategies for Venous Thrombosis in Spaceflight and Exploration
-
Apr 1, 2026, 14:44Chad Mineo: Platelet-Rich Plasma as an Adjunct to Rehabilitation in Grade 2 Hamstring Injuries
-
Apr 1, 2026, 14:41How Psychosocial Care Transforms Fear into Clarity and Stability – WFH
-
Apr 1, 2026, 14:23Ingo Ahrens: When Bleeding Poses a Greater Risk Than Ischemia
-
Apr 1, 2026, 13:48Anas Ibraheem: Apixaban Shows Superior Safety in Acute VTE While Matching Rivaroxaban Efficacy